SNSF
EJP Rare Diseases
Depending on the call
Last verified:
The EJP Rare Diseases programme funds transnational consortia to conduct research on rare diseases, with Swiss researchers fully eligible to participate. SNSF funds the Swiss partner(s) directly through this scheme, which requires a minimum of three countries per consortium. Calls are recurring and submission rules vary by call; consult the national annex for each round.
Details
| Funder | SNSF |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Frequency | Annual |
| Eligible countries | CH |
Eligibility & scope
European Joint Programme on rare diseases. Swiss researchers are fully eligible; SNSF funds the Swiss partner. Transnational consortium required. See national annex of each call for Swiss-specific submission requirements.
Who Should Apply
- •Swiss researchers and research groups working on rare disease topics
- •Applicants able to form or join a consortium spanning at least 3 countries
- •Fundamental and translational researchers in rare disease domains
- •Teams willing to coordinate across borders and comply with each call's national annex requirements
Key Dates
- •Deadline varies by call; consult the EJP Rare Diseases and SNSF websites for upcoming rounds
- •Multi-country consortium formation required before submission
- •Project duration and funding level vary by call
Tips for Applicants
- ✓Each call publishes a national annex specific to Switzerland, this document governs SNSF funding rules and submission format; do not rely on the main call text alone.
- ✓Consortium strength is critical: partner institutions must be formally committed and named in the application; informal agreements will not pass SNSF review.
- ✓Coordinate with your international partners early; SNSF has strict co-funding and co-authorship rules for transnational calls.
Frequently Asked Questions
Can Swiss researchers apply to EJP Rare Diseases?
Yes, Swiss researchers are fully eligible and SNSF funds the Swiss partners directly.
Is a consortium required for EJP Rare Diseases?
Yes, a minimum of 3 countries must be represented in the consortium.
Where do I find the deadline and submission rules for EJP Rare Diseases?
Deadline and submission rules vary by call; consult the national annex published by SNSF for each round, as it governs Swiss eligibility and funding conditions.
Related on Grantsby
- SNSF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from SNSF
Weave Lead Agency – South Africa
Deadline: 28 Aug 2026Weave Lead Agency – Croatia
Deadline: 1 Oct 2026Weave Lead Agency – Austria
Deadline: 1 Oct 2026Weave Lead Agency – Germany
Deadline: 1 Oct 2026Weave – Sweden
Deadline: 1 Oct 2026
Browse Related
Could EJP Rare Diseases be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →